Hospira patent dispute revived
14-09-2015
Pfizer’s Hospira buyout approved in Australia and Canada
18-08-2015
European Commission approves Pfizer’s buyout of Hospira
06-08-2015
Pfizer’s buyout of Hospira, which is set to boost Pfizer’s biosimilars portfolio but has been the subject of anti-competition concerns, will be completed next month after gaining final approval.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Pfizer, Hospira, anti-competition, Federal Trade Commission, drugs, pharma
